Three investigational drugs will be studied in a worldwide clinical trial to determine whether they can prevent Alzheimerâ€™s disease. In people with inherited mutations that cause early-onset Alzheimerâ€™s, the study will seek to identify whether the drugs can improve Alzheimerâ€™s disease biomarkers and prevent the loss of cognitive function.

Get the latest industry news, event updates, and more from Managed healthcare Executive.

Subscribe Now!

Investigational drugs to be studied for preventing Alzheimer's

Newsletter